Ownership history in MORGAN STANLEY · 2 quarters on record
This page tracks every 13F SEC filing in which MORGAN STANLEY reported a position in PROPANC BIOPHARMA INC (PPCB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 1 | — | 0% | 0.00% | $1 | $0.54 |
| 2025 Q3 | INITIATED | 1 | — | — | 0.00% | $2 | $1.70 |